• Profile
Close

Long-term treatment with leuprorelin for spinal and bulbar muscular atrophy: Natural history-controlled study

Journal of Neurology, Neurosurgery & Psychiatry Aug 16, 2017

Hashizume A, et al. – This natural history–controlled study aims to assess the prognosis and progression of spinal and bulbar muscular atrophy (SBMA), a rare X–linked motor neuron disorder caused by trinucleotide repeat expansion in the AR (androgen receptor) gene, after long–term androgen suppression with leuprorelin acetate treatment. In subjects with SBMA, long–term treatment with leuprorelin acetate seems to delay the functional decline and suppress the incidence of pneumonia and death.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay